|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR1800015487 |
|
最近更新日期: Date of Last Refreshed on: |
2018-04-03 06:24:17 |
|
注册时间: Date of Registration: |
1990-01-01 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
中国初产妇产后盆底状况队列研究 |
|
Public title: |
The Pelvic Floor Muscle Function in Chinese Primipara, a One-year Cohort Study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
中国初产妇产后盆底状况队列研究 |
|
Scientific title: |
The Pelvic Floor Muscle Function in Chinese Primipara, a One-year Cohort Study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
孙智晶 |
研究负责人: |
朱兰 |
|
Applicant: |
Zhijing Sun |
Study leader: |
Lan Zhu |
|
申请注册联系人电话: Applicant telephone: |
+86 13651314354 |
研究负责人电话:
Study leader's |
+86 13911714696 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
sunzhj2001@sina.com |
研究负责人电子邮件: Study leader's E-mail: |
zhu_julie@vip.sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市东城区帅府园1号北京协和医院妇产科 |
研究负责人通讯地址: |
北京市东城区帅府园1号北京协和医院妇产科 |
|
Applicant address: |
1 Shuaifuyuan, Dongcheng District, Beijing, China |
Study leader's address: |
1 Shuaifuyuan, Dongcheng District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国医学科学院北京协和医院 |
||
|
Applicant's institution: |
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences |
||
|
研究负责人所在单位: |
中国医学科学院北京协和医院 |
||
|
Affiliation of the Leader: |
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
JS-1549 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国医学科学院北京协和医院伦理审查委员会 |
||
|
Name of the ethic committee: |
the PUMCH ethics committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2018-03-27 00:00:00 | ||
|
伦理委员会联系人: |
徐辉 |
||
|
Contact Name of the ethic committee: |
Hui Xu |
||
|
伦理委员会联系地址: |
北京市东城区帅府园1号中国医学科学院北京协和医院伦理审查委员会 |
||
|
Contact Address of the ethic committee: |
the PUMCH ethics committee, 1 Shuaifuyuan, Dongcheng District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
中国医学科学院北京协和医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市东城区帅府园1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1 Shuaifuyuan, Dongcheng District, Beijing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国医学科学院医学与健康科技创新工程(重大协同创新项目) |
||||||||||||||||||||||
|
Source(s) of funding: |
Medical and health science and technological innovation project of Chinese Academy of Medicine Sciences(Major Collaborative Innovation Projects ) |
||||||||||||||||||||||
|
研究疾病: |
女性盆底功能障碍性疾病 |
||||||||||||||||||||||
|
Target disease: |
female pelvic floor dysfunction |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
预后研究 |
||||||||||||||||||||||
|
Study type: |
Prognosis study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
中国初产妇不进行干预,观察盆底自然恢复情况,设定产后6周、12周、1年对产后盆底肌肉功能状况和压力性尿失禁发生情况进行跟踪调查。 |
||||||||||||||||||||||
|
Objectives of Study: |
A prospective cohort study recruiting subjects to evaluate the postpartum pelvic floor function is designed to observe the pelvic floor function and urinary incontinence at 6 weeks, 3 months and 1 year postpartum in Chinese primipara without intervention. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
初次分娩的妇女 (包括自然产和剖宫产) |
||||||||||||||||||||||
|
Inclusion criteria |
1. Women who give birth for the first time (Including vaginal delivery and cesarean section); |
||||||||||||||||||||||
|
排除标准: |
本次孕前尿失禁病史 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. A history of incontinence before pregnancy; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2018-04-01 00:00:00至 To 2020-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2018-04-01 00:00:00 至 To 2019-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
前瞻队列研究,无随机 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
prospective cohort study, no random |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2021年6月,中国临床试验注册中心,www.chictr.org.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
In June,2016. www.chictr.org.cn |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
采取EDC方式进行采集数据 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
electronic data capture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |